Close Menu
Technology Mag

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    The Ploopy Knob is an open-source control dial for your PC

    July 4, 2025

    Laid-off workers should use AI to manage their emotions, says Xbox exec

    July 4, 2025

    Despite Protests, Elon Musk Secures Air Permit for xAI

    July 4, 2025
    Facebook X (Twitter) Instagram
    Subscribe
    Technology Mag
    Facebook X (Twitter) Instagram YouTube
    • Home
    • News
    • Business
    • Games
    • Gear
    • Reviews
    • Science
    • Security
    • Trending
    • Press Release
    Technology Mag
    Home » The World’s First Malaria Vaccine Program for Children Starts Now
    Science

    The World’s First Malaria Vaccine Program for Children Starts Now

    News RoomBy News RoomFebruary 8, 20243 Mins Read
    Facebook Twitter Pinterest LinkedIn Reddit WhatsApp Email

    Malaria expert Brian Greenwood had once resigned himself to the possibility that a successful vaccine for the disease might not become available in his lifetime. Now, at 86 years old, the moment he’s spent four decades working toward has arrived.

    “It’s been a long journey with many ups and downs,” says Greenwood, still an active researcher at the Royal Society of Tropical Medicine and Hygiene, leading vaccine trials across Africa. “The first attempts to develop a malaria vaccine through studies in birds were done over 100 years ago.”

    Beginning today, Cameroon, a Central African nation which experiences 2.7 million cases of the disease each year, will start rolling out the world’s first routine childhood malaria immunizations using a vaccine called RTS,S or Mosquirix, made by the pharma company GlaxoSmithKline. The vaccine targets sporozoites, the transmissible forms of the malaria parasite, and neutralizes them before they can enter the liver and multiply in their thousands.

    With 48 percent of all hospital admissions and 67 percent of childhood deaths in Cameroon linked to malaria, the hope is that this new rollout will help relieve the considerable burden the disease places on the country’s health care system.

    “The impact of this vaccine goes beyond the medical benefits examined in clinical trials,” says Mohammed Abdulaziz, head of disease control and prevention at Africa CDC. “Malaria is a major reason for school absenteeism, anemia, and impaired cognitive development. This vaccine can help break the cycle of adversity plaguing our youth for a long time.”

    Despite efforts to eradicate mosquitos carrying the Plasmodium falciparum parasite—the deadliest source of malaria on the African continent—and the use of protective nets and coating the walls of houses with insecticides, malaria still killed 608,000 people in 2022. Ninety-five percent of the fatalities were in Africa; young children, whose immune systems are still developing, are by far the most vulnerable. According to the charity UNICEF, a child under 5 dies of malaria nearly every minute.

    The rollout is expected to expand swiftly. Twelve African countries will receive a combined total of 18 million doses of RTS,S over the next two years through Gavi, the vaccine alliance that ensures immunization access in some of the world’s poorest nations. Cameroon will receive 662,000 doses in 2024, with Burkina Faso, Sierra Leone, Benin, and others set to follow. All the vaccines so far are earmarked for children due to availability constraints.

    “We have more than 30 African countries today who have expressed interest in a routine malaria vaccination program,” says Aurélia Nguyen, chief program officer at Gavi.

    The vaccine will undoubtedly save lives. In October, the World Health Organization announced that a previous pilot rollout of RTS,S in hundreds of thousands of children across Ghana, Kenya, and Malawi over four years had reduced deaths by 13 percent and severe cases by 22 percent.

    But a perceived lack of urgency has already received criticism. The efficacy of RTS,S was first demonstrated in clinical trials as far back as 1998, yet the WHO did not officially recommend its use until 2021. More than 18 million people, mainly children, are thought to have died of the disease since those initial trials.

    Share. Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Email
    Previous ArticleApple Beats an Apple Watch Lawsuit
    Next Article You can stream the Super Bowl for free with this one-month Paramount Plus deal

    Related Posts

    Feeling Hoarse? You Might Have the New ‘Stratus’ Covid Variant

    July 4, 2025

    A European Startup’s Spacecraft Made It to Orbit. Now It’s Lost at Sea

    July 3, 2025

    The Next Acetaminophen Tablet You Take Could Be Made From PET

    July 2, 2025

    How Much Energy Does AI Use? The People Who Know Aren’t Saying

    July 2, 2025

    Space Elevators Could Totally Work—if Earth Days Were Much Shorter

    July 2, 2025

    Methane Pollution Has Cheap, Effective Solutions That Aren’t Being Used

    July 2, 2025
    Our Picks

    Laid-off workers should use AI to manage their emotions, says Xbox exec

    July 4, 2025

    Despite Protests, Elon Musk Secures Air Permit for xAI

    July 4, 2025

    This Is Why Tesla’s Robotaxi Launch Needed Human Babysitters

    July 4, 2025

    Fairphone 6 gets a 10/10 on repairability

    July 4, 2025
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    Don't Miss
    News

    New Galaxy Z Fold 7 leaks may give first real look at Samsung’s slimmer foldable

    By News RoomJuly 4, 2025

    Samsung’s upcoming Galaxy Z Fold 7 has been given the thinner, sleeker glow-up we expected,…

    This is not a tattoo robot

    July 4, 2025

    What Could a Healthy AI Companion Look Like?

    July 4, 2025

    A Former Chocolatier Shares the 7 Kitchen Scales She Recommends

    July 4, 2025
    Facebook X (Twitter) Instagram Pinterest
    • Privacy Policy
    • Terms of use
    • Advertise
    • Contact
    © 2025 Technology Mag. All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.